Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04005690	Targeted Pathway Inhibition in Patients With Pancreatic Cancer	recruiting	Early Phase 1	90	OHSU Knight Cancer InstituteOTHER	1	Sep 4, 2026	clinicaltrials
NCT05141643	Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer	active not recruiting	Early Phase 1	30	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 3, 2026	clinicaltrials